Fieldpoint Private Securities’s Varian Medical Systems, Inc. VAR Stock Holding History

Fieldpoint Private Securities’s Portfolio VAR Stock Details VAR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-364	Closed	-$64K	–	1685
2021 Q1	$64K	Buy	364 +12	+3%	+$2.11K	0.01%	513
2020 Q4	$62K	Buy	+352	New	+$61K	0.01%	454
2020 Q1	–	Sell	-300	Closed	-$43K	–	621
2019 Q4	$43K	Sell	300 -91	-23%	-$11.6K	0.01%	465
2019 Q3	$47K	Buy	391 +91	+30%	+$10.8K	0.02%	397
2019 Q2	$41K	Hold	300	–	–	0.01%	443
2019 Q1	$43K	Hold	300	–	–	0.02%	301
2018 Q4	$34K	Hold	300	–	–	0.02%	304
2018 Q3	$34K	Sell	300 -100	-25%	-$11.3K	0.01%	329
2018 Q2	$45K	Hold	400	–	–	0.02%	318
2018 Q1	$49K	Buy	+400	New	+$47.7K	0.02%	296
2017 Q4	–	Sell	-400	Closed	-$40K	–	602
2017 Q3	$40K	Hold	400	–	–	0.02%	417
2017 Q2	$41K	Buy	+400	New	+$38.5K	0.03%	117

Other funds holding VAR

WAM

Westport Asset Management Southport, Connecticut $245M AUM 15.03% 1-Year Est. Return

Fieldpoint Private Securities's VAR Position: Q2 2021 in Review

Fieldpoint Private Securities sold out of Varian Medical Systems, Inc. (VAR) in Q2 2021, closing a stake of 364 shares — an estimated $64K sold.

Fieldpoint Private Securities first reported a position in VAR in Q2 2017 and held it in 12 quarters. The position peaked at $64K in Q1 2021. 1 fund tracked by Wall St. Rank holds VAR as of Q2 2021.

Fieldpoint Private Securities reported no remaining Varian Medical Systems, Inc. position as of Q2 2021 after selling out during the quarter.
Fieldpoint Private Securities sold 364 Varian Medical Systems, Inc. shares in Q2 2021, an estimated $64K.
Fieldpoint Private Securities first reported a position in Varian Medical Systems, Inc. in Q2 2017 and held it in 12 quarters.
Fieldpoint Private Securities's Varian Medical Systems, Inc. position peaked at $64K in Q1 2021.
1 fund tracked by Wall St. Rank held Varian Medical Systems, Inc. as of Q2 2021.

Based on Fieldpoint Private Securities's 13F filing for Q2 2021, filed 12 Aug 2021.